Latest Risk Management News

Barton Gold Holdings has initiated an 8,000m drilling campaign at its Challenger Gold Project, aiming to upgrade resources and deliver a Definitive Feasibility Study by mid-2026. This move sets the stage for restarting the Central Gawler Mill and advancing multiple regional assets.

Haranga Resources has converted key performance rights into shares following milestone achievements and extended the escrow period on vendor shares, while progressing drilling at its Lincoln and Ibel South gold projects.

ResMed Inc. reported robust financial results for Q2 FY2026, driven by strong demand in its Sleep and Breathing Health and Residential Care Software segments. The company also navigates ongoing patent litigation while maintaining solid liquidity and shareholder returns.

Botala Energy is progressing its Serowe Coal Bed Methane project in Botswana, backed by a significant investment from the Mineral Development Company of Botswana and aiming for first gas production in 2026 to help address Southern Africa’s looming gas shortage.

Qualitas Real Estate Income Fund has concluded its recent rights issue without issuing any shortfall units, a move it says benefits unitholders. The decision finalises the capital raising process initiated in November 2025.

HITIQ has made significant strides in expanding its concussion management technology, PROTEQT©, into North America and Australian retail, backed by strong research partnerships and a successful capital raise.

Pacific Lime and Cement Limited reports steady progress on its Central Lime Project in Papua New Guinea, securing key government agreements and strategic partnerships while maintaining financial discipline.

Po Valley Energy has adopted its first-ever dividend policy and announced plans to pay a maiden dividend, signalling confidence in its cash flow and future growth prospects.

WhiteHawk Limited reported steady Q4 revenue and advanced multiple government and academic contracts in the US and Australia, underpinning its growth in cybersecurity services.

True North Copper reports significant drilling success at Mt Oxide’s Aquila Prospect and advances its Cloncurry Copper Project with a new scoping study, backed by a $12.5 million capital raise to fund 2026 growth.

Neurizon Therapeutics has locked in a $6 million cash rebate from the Australian Government’s R&D Tax Incentive, underpinning its upcoming HEALEY ALS Platform Trial with first patient dosing slated for early 2026.

Avenira Limited has made significant strides in developing its Wonarah Phosphate Project, bolstered by strategic operational appointments and advancing infrastructure plans. Meanwhile, exploration at the Jundee South Gold Project is set to commence in 2026 amid ongoing regulatory challenges.